141 related articles for article (PubMed ID: 9157977)
1. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.
He D; Mu ZM; Le X; Hsieh JT; Pong RC; Chung LW; Chang KS
Cancer Res; 1997 May; 57(10):1868-72. PubMed ID: 9157977
[TBL] [Abstract][Full Text] [Related]
2. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
Le XF; Vallian S; Mu ZM; Hung MC; Chang KS
Oncogene; 1998 Apr; 16(14):1839-49. PubMed ID: 9583681
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis.
He D; Nan X; Chang KS; Wang Y; Chung LW
Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein.
Lin SH; Nishino M; Luo W; Aumais JP; Galfione M; Kuang J; Yu-Lee LY
Oncogene; 2004 Apr; 23(14):2499-506. PubMed ID: 14676831
[TBL] [Abstract][Full Text] [Related]
7. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
8. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.
Liu JH; Mu ZM; Chang KS
J Exp Med; 1995 Jun; 181(6):1965-73. PubMed ID: 7759992
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
10. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
11. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
[TBL] [Abstract][Full Text] [Related]
12. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
13. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
[TBL] [Abstract][Full Text] [Related]
14. A role for the WWOX gene in prostate cancer.
Qin HR; Iliopoulos D; Semba S; Fabbri M; Druck T; Volinia S; Croce CM; Morrison CD; Klein RD; Huebner K
Cancer Res; 2006 Jul; 66(13):6477-81. PubMed ID: 16818616
[TBL] [Abstract][Full Text] [Related]
15. Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells.
Li L; He DL
Acta Pharmacol Sin; 2005 May; 26(5):610-5. PubMed ID: 15842782
[TBL] [Abstract][Full Text] [Related]
16. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
Guan M; Tripathi V; Zhou X; Popescu NC
Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde.
Steiner MS; Zhang X; Wang Y; Lu Y
Cancer Res; 2000 Aug; 60(16):4419-25. PubMed ID: 10969787
[TBL] [Abstract][Full Text] [Related]
20. Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.
Taj MM; Tawil RJ; Engstrom LD; Zeng Z; Hwang C; Sanda MG; Wechsler DS
Prostate; 2001 May; 47(3):194-204. PubMed ID: 11351349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]